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Rupture of vulnerable atherosclerotic plaques is the leading cause of acute myocardial
infarction (AMI) and unstable angina pectoris (UA). However, it still lacks an effective
therapy to stabilize the vulnerable atherosclerotic plaques. Numerous reports have shown
that upregulation of MMP-9 (matrix metalloproteinase-9) and EMMPRIN (extracellular
matrix metalloproteinase inducer) in macrophages is involved in the progression and
development of vulnerable plaques. Here we evaluated the impact of curcumin on the
expression of MMP-9 and EMMPRIN in macrophages. Macrophages were pretreated
with curcumin or specific inhibitors (p38 MAPK inhibitor, NF-κB p65 inhibitor) for 1 h,
then cells were cultured with oxLDL for indicated time. Real-time PCR and Western blot
analysis were used to evaluate the expression of mRNA and proteins. Translocation
of NF-κB p65 was detected by using laser confocal microscopy. Here we showed
that curcumin attenuated the MMP-9 and EMMPRIN expression in oxLDL stimulated
macrophages. Further studies revealed that curcumin inhibited oxLDL induced NF-κB
activation and p38 MAPK phosphorylation. These findings illustrated that curcumin can
inhibit the expression of EMMPRIN and MMP-9 in oxLDL stimulated macrophages
through down regulation of NF-κB and p38 MAPK signaling pathways, which might be
the molecular mechanism for the anti-atherosclerotic effect of curcumin.
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INTRODUCTION
Atherosclerosis is defined as a chronic inflammatory disease in the arterial wall, and is closely
correlative with accumulation of macrophages, dysfunction of endothelial cells, and activation
of immune cells (Fuster and Kovacic, 2014; Zeller and Srivastava, 2014; Gimbrone and Garcia-
Cardena, 2016). Monocytes recruitment and their differentiation into macrophages in the
subendothelial space, macrophages take up lipids from lipoproteins and transforming into foam
cells, which further enhances inflammation and atherogenesis (Tabas and Bornfeldt, 2016). Among
the inducer of inflammations, Oxidized low-density lipoprotein (oxLDL) is recognized as a key
activator of inflammation and a critical cardiovascular risk (Di Pietro et al., 2016). It is proved that
monocyte-derivedmacrophages play a critical role in the atherosclerosis initiation and progression.
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Emerging data have demonstrated that local inflammation
induced by oxLDL is the major cause of atherosclerotic plaque
fracture, which leads to stroke and myocardial infarction (Libby
and Aikawa, 2002; Belovici and Pandele, 2008). Since the first
historical description of plaque rupture in 1,844, several key
mechanisms about plaque vulnerability have been detected.
Increased evidence from genetic studies and emerging clinical
research suggest that MMP-9 (matrix metalloproteinase-9) is
one of the most risk factors for inducing plaque rupture
(Fuster and Kovacic, 2014; Kobayashi et al., 2016). MMP-9 is
a member of the MMPs, which are enzymes that can degrade
ECM (extracellular matrix). EMMPRIN (extracellular matrix
metalloproteinase inducer), also termed CD147, is a 58-kDa
cell surface glycoprotein described first in tumor cells. It has
been reported to be secreted by macrophages in response to
oxLDL stimulation and implicated in plaque rupture (Moreau
et al., 1999; Chen et al., 2011). Monocyte-derived macrophages
in atherosclerotic plaques secrete MMP-9, which contributes
to plaque rupture (Cipollone et al., 2003). Over-expression
of MMP-9 and EMMPRIN in monocytes/macrophages result
in plaque progression and destabilization. In humans, plasma
concentrations of MMPs were significantly increased in patients
with acute coronary syndromes (ACS) or coronary artery disease
(CAD) compared with those in healthy controls (Blankenberg
et al., 2003; Fitzsimmons et al., 2007; Bencsik et al., 2015).
Although recent advances have been made in PCI (percutaneous
coronary intervention) and drug therapies, identifying a new
plaque vulnerability therapy is still a challenging work in
progress. Here, we speculate that EMMPRIN and MMP-9 would
be critical therapeutic targets, suppressing the expression of them
can inhibit plaque rupture or retard atherosclerosis.
Curcumin is a safe and effective natural polyphenolic
compound extract from curcuma longa and turmeric and found
to be very valuable in anti-cancer, anti-oxidant, and anti-
inflammatory processes (Bimonte et al., 2016; Kunnumakkara
et al., 2016). Studies strongly support that curcumin is of
potential therapeutic value in atherosclerosis and CAD (Sikora
et al., 2010; Chen et al., 2015). Moreover, curcumin suppresses
oxLDL stimulated CD36 expression via p38 MAPK pathway and
prevents the migration of human aortic smooth muscle cells
(HASMCs) by reducing the expression of MMP-9 (Yu and Lin,
2010). In our previous study, we found curcumin decreased
expression of MMP-9, MMP-13 in PMA induced human
monocyte cells (Cao et al., 2014). However, the mechanisms
of curcumin’s effects on EMMPRIN and MMP-9 expression
in macrophages have not been elucidated. In this study, we
determined the regulation of MMP-9 and EMMPRIN expression
by curcumin in oxLDL stimulated macrophages and identified its
molecular mechanisms.
MATERIALS AND METHODS
Cell Culture and Methods
To evaluate the effects of curcumin on uptake of oxidized
low density lipoprotein (oxLDL) in PMA induced macrophage,
human monocyte cell line THP-1 (ATCC, Rockville, MD) were
seeded on six-well plates at a density of 106 cells per well in RPMI
1640 medium containing 10% heat-inactivated Fetal calf serum
(Gibco, Grand Island, NY, USA). To induce the differentiation of
THP-1, cells were treating with 100 nM phorbol 12-myristate 13-
acetate (PMA, Calbiochem, San Diego, CA) for 48 h (Tsuchiya
et al., 1982). To study dose-dependent effects of curcumin, the
PMA induced macrophages were treated with curcumin (0 to
50µM, Sigma, USA), 10µM SB203580 (p38 MAPK inhibitor,
Sigma, USA), or 20µM BAY-11-7082 (NF-κB p65 inhibitor,
Sigma, USA) for 1 h, and then stimulated with oxLDL (50 ug/L,
Oxidized Human LDL, Peking Union-Biololgy Co. Ltd.) at the
indicated time. To study time-dependent effects of curcumin,
macrophages were pretreated with vehicle or curcumin (25µM)
for 1 h, followed by oxLDL (50 ug/L) for 1, 3, 6, or 12 h, then the
cells were harvest for further analysis.
RNA Isolation, cDNA Synthesis, and
Real-Time PCR
Real-time PCR was performed to determine gene expression of
EMMPRIN, MMP-9. Total RNA was isolated from cells using
Trizol reagent (Invitrogen), cDNAwas synthesized using Reverse
Transcription Kit (Takara) according to the manufacturer’s
instructions. Quantification real-time PCR were performed by
SYBR Premix Ex Taq Kit (TaKaRa Code DRR041) as previously
described (Meng et al., 2012). The primer sequences of PCR are
listed in Table 1. GAPDH was used for normalization.
Preparation of Cell Lysates and Nuclear
Fraction, and Immunoblotting
Cells were lysed with 100 mM phenylmethanesulfonyl fluoride,
and the protein extracts were denatured and loaded onto
a 10% SDS-PAGE gel. To measure IκB-α phosphorylation
and nuclear p65 expression levels, NE-PER nuclear and
cytoplasmic extraction reagents were used to isolated protein
from the cytoplasm or nuclear. Then, western blot analysis
were performed as we reported previously (Huang et al., 2012;
Cao et al., 2014). Briefly, membranes were first incubated with
primary antibodies for Lamin B (Sigma-Aldrich, St. Louis,
MO), EMMPRIN (Life Technologies, USA), MMP-9, p-p38,
p38, p-ERK, ERK, p-JNK, JNK, p-IκB-α, p65, or β-actin (Cell
Signaling Technology, Boston, MA) then incubated with far-red
fluorescent secondary antibodies (Life technologies, USA). All
signals were conducted by the Odyssey imaging system (Li-cor,
USA).
Gelatin Zymography
Gelatin zymography were performed as described in our previous
study (Cao et al., 2014). PMA induced macrophages were seeded
in a six-well plate at the density of 3 × 105 cells per well. To
TABLE 1 | Real time-pCR primers of MMP-9 and EMMPRIN.
Target
genes
Forward (5′–3′) Reverse (5′–3′)
EMMPRIN TTGGAGGTTGTAGGACCGGCGA TGGGACCCTGCCCTTCAAACCA
MMP-9 TGACGCCGCTCACCTTCACT CGCGCCATCTGCGTTTCCAA
GAPDH CCGCATCTTCTTTTGCGTCGCC TCTCAGCCTTGACGGTGCCA
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study dose-dependent effects of curcumin, the PMA induced
macrophages were treated with curcumin (0 to 50µM), 10µM
SB203580 (p38 MAPK inhibitor, Sigma, USA), or 20µM BAY-
11-7082 (NF-κB p65 inhibitor, Sigma, USA) for 1 h, and then
stimulated with oxLDL (50 ug/L) for the indicated time. To
study time-dependent effects of curcumin, macrophages were
pretreated with vehicle or curcumin (25µM) for 1 h, followed by
oxLDL (50 ug/L) for 1, 3, 6, or 12 h, then the cells were harvest
for further analysis. The culture supernatants were collected,
10µl aliquots of the culture supernatant were loaded onto
a 10% polyacrylamide gel containing 1 mg/ml gelatin. After
electrophoresis, gels were washed twice with 2.5% Triton X-100
(37◦C, 15 min) and then gels were incubated at 37◦C for 11 h in
developing buffer containing 10mMTris Base, 40mMTris–HCl,
200mMNaCl, 10mM CaCl2, 0.02% Brij. Gels were subsequently
stained with 0.5% (w/v) Coomassie Blue R-250 for 2 h followed by
destaining with a solution containing 50% methanol, 10% glacial
acetic acid, 40% water. MMP-9-digested regions were visualized
as light bands against a dark background. An image of each gel
was detected by an Odyssey imaging system (Li-cor, USA).
Confocal Laser Scanning Fluorescence
Microscopy Analyze the Translocation of
NF-κB
PMA induced macrophages were cultured on microcover glasses
in a six-well plate, the cells were pretreated with or without
25µM curcumin 1 h, then they were stimulated with oxLDL
in the indicated time (1, 2, 3, and 6 h). The macrophages
were labeled with immunofluorescence using cellular NF-κB
translocation kit (Beyotime Biotech) as described in our previous
study (Huang et al., 2012). Briefly, at timed intervals, cells were
fixed and permeabilized, after staining with NF-κB p65 antibody,
cells were incubated with a rabbit IgG antibody conjugated with
Cy3. The Nucleus were stained by DAPI, after the cells were
incubated with it for 5 min. The activation of NF-κB p65 was
visualized by using confocal microscopy (FluoViewTM FV1000,
Olympus).
Statistical Analysis
Multiple group comparisons were performed using oneway
ANOVA. P < 0.05 was considered statistically significant. All
experiments were performed at least three times.
RESULTS
Curcumin Inhibited the Expression of
MMP-9 and EMMPRIN in
oxLDL-Stimulated Macrophages
Elevated MMP-9 and EMMPRIN expression level was previously
reported in oxLDL-stimulated macrophage. Because EMMPRIN
can up-regulate the expression of MMP-9, we first need to
know whether curcumin has an effect on MMP-9 expression.
We pretreated THP-1 differentiated macrophages with different
concentrations of curcumin (6.25–50µM) for 1 h, then the
cells were stimulated with 50 ug/L oxLDL for 12 h. Based
FIGURE 1 | Curcumin inhibits MMP-9 and EMMPRIN in oxLDL-stimulated macrophages. (A–D) Curcumin suppresses EMMPRIN and MMP-9 expression in
oxLDL-stimulated macrophages at dose-dependent manner (6.25, 25, and 50 µM). (E,F) Curcumin reduced MMP-9 and EMMPRIN expression at time-dependent
manner (3, 6, and 12 h). Real-time PCR and Western blot were used to measure the mRNA and protein level. *P < 0.05 vs. oxLDL group, **P < 0.01 vs. CTL group
(Control group). CTL group suggest the cells incubated in a medium with DMSO. 6.25, 25, and 50 µM group suggest that indicated concentrations of curcumin were
used to pretreated macrophages for 1 h, and then they were stimulated with 50 ug/L oxLDL for another 12 h. 3, 6, and 12 h indicates that macrophage were
pretreated with curcumin (25 µM) for different time intervals (3, 6, and 12 h).
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on the western blot and real-time PCR analysis, we found
that curcumin inhibited MMP-9 expression (Figures 1A–C)
at a dose-dependent manner. Also, as shown in Figure 1,
curcumin inhibited EMMPRIN expression. Furthermore, THP-
1 differentiated macrophages were pretreated with curcumin
(25µM) for 1 h, then the expression level of MMP-9 and
EMMPRIN were measured at different time points (3, 6,
and 12 h) (Figures 1D–F). Curcumin significantly reduced
the MMP-9 and EMMPRIN expression at a time-dependent
manner. These results demonstrated that curcumin can inhibit
the MMP-9 and EMMPRIN expression in oxLDL-stimulated
macrophages.
Curcumin Suppressed MMP-9 and
EMMPRIN Expression by Inhibiting
Activation of NF-κB
As a nuclear transcription factor, NF-κB plays a key role for
regulating the expression of genes involved in inflammation.
FIGURE 2 | Curcumin suppresses the phosphorylation of IκB-α (p-IκB-α) and nuclear translocation of p65 in oxLDL-stimulated macrophages.
Macrophages were pretreated with vehicle or curcumin (25µM) for 1 h, followed by oxLDL (50 uFg/L) for 1, 3, and 6 h. The key protein levels, p-IκB-α in the cytosolic
part and NF-κB p65 subunit, were assessed by Western blot analysis. (A,B) Effect of curcumin on phosphorylation of IκB-α in oxLDL-stimulated macrophages at
different time points. (C,D) Effect of curcumin on p65 expression (p65 translocation) at different time points. (E,F) Macrophages were pretreated with vehicle,
curcumin or p65-specific inhibitor (BAY-11-7082, 20µM). p65-specific inhibitor significantly decreased MMP-9 and EMMPRIN expression. *P < 0.05 when compared
with the control group.
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The NF-κB mediated pathway was involved in MMP-9 and
EMMPRIN expression in previous study (Kim et al., 2009; Huang
et al., 2012), we thus determined to test whether the inhibition
of MMP9 and EMMPRIN expression in oxLDL-simulated
macrophages by curcumin is through regulating NF-κB pathway.
Nuclear protein extraction was quantified by western blot for the
p65 subunit and in oxLDL (50 ug/L) stimulated macrophages,
level of p65 subunit in nuclear was increased (Figures 2C,D).
Meanwhile, the phosphorylation of IκB-α (p-IκB-α) in cytoplasm
was elevated at indicated times (1, 3, and 6 h) (Figures 2A,B).
In contrast, curcumin (25µM) treatment blocked the nuclear
translocation of p65 (Figures 2C,D) and the phosphorylation of
IκB-α (Figures 2A,B). As shown in Figure 3, the same tendency
was found, the stain levels of p65 diminished in curcumin-treated
macrophages. In addition, we examine MMP-9 and EMMPRIN
expression in oxLDL-stimulated macrophages after treated with
p65-specific inhibitor (BAY-11-7082). As show in Figures 2E,F,
blockade of p65 attenuated the expression of MMP-9 and
EMMPRIN. In summary, our results suggested that curcumin
significantly suppresses MMP-9 and EMMPRIN expression via
the inhibition of NF-κB signaling pathway.
Curcumin Reduced oxLDL Stimulated
MMP-9 and EMMPRIN Expression by
Inhibiting p38 MAPK Phosphorylation
It has been previously reported oxLDL can stimulate the
MAPK pathways, including ERK, p38 and JNK. To elucidate
whether curcumin inhibited oxLDL-induced MMP-9 and
EMMPRIN expression through regulating MAPK signaling
pathways, we pretreated the THP-1 differentiated macrophages
for 1 h, then cells were cultured with oxLDL for 10, 30, or
60min. Western blot data showed that curcumin inhibited p38
MAPK phosphorylation induced by oxLDL (Figures 4A,D). To
further confirm that the MMP-9 and EMMPRIN expression
can be inhibited through the inhibition of p38 MAPK
phosphorylation, we examined their expression in oxLDL
stimulated macrophages after treated with p38-specific inhibitor
(SB203580). Blockade of p38 MAPK attenuated MMP-9 and
EMMPRIN expression (Figures 4E,F). In addition, curcumin
also inhibit the phosphorylation of JNK (Figures 4A,C), whereas
it showed no inhibitory effect on phosphorylation of ERK
(Figures 4A,B). Here, the data indicated that oxLDL-induced
MMP-9 and EMMPRIN expression, in THP-1 differentiated
macrophages is associated with the p38 MAPK pathway and that
curcumin may suppress them via this signaling pathway.
DISCUSSION
The treatment of ACS has been significantly improved by
statins and drug-eluting stents. However, coronary events
continue to be the leading cause of death over the development
countries. Coronary artery plaque vulnerability and rupture is
the primary cause of ACS. Accumulating evidence now indicate
that overexpression of MMP-9 and EMMPRIN is critical in the
development of plaque formation and rupture. Here, we found
that curcumin effectively suppressed the mRNA and protein
FIGURE 3 | Confocal laser scanning microscope observe the effect of
curcumin on the translocation of NF-κB p65 in oxLDL-treated
macrophages. The Cy3-conjugated secondary antibody was used to analyze
the localization of NF-κB p65. Cell nucleus were stained by DAPI. The
fluorescence images were observed by confocal laser scanning microscope,
Red marked NF-κB p65, light blue represents nuclei with DAPI. Images were
merged and a purple fluorescence indicate the areas of co-localization (three
independent experiments). THP-1 induced macrophages were pretreated with
vehicle or curcumin (25 µM) for 1 h, and exposed to oxLDL (50 ug/L) for 1, 3,
and 6 h. It was found a significant translocation of p65 to the cell nucleus after
cells were stimulated with oxLDL for 3 h. In treatment groups, cells were
pretreated with curcumin (25 µM) for indicated times, NF-κB p65 was retained
significantly in the cytoplasm.
expression of both MMP-9 and EMMPRIN in oxLDL-stimulated
macrophages.
The role of curcumin in foam cell formation and inflammation
has been previously reported (Hasan et al., 2014). Moreover, our
previous studies suggested that curcumin down-regulated MMPs
expression in monocytes/macrophages transdifferentiation (Cao
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FIGURE 4 | Curcumin inhibits p38 and JNK phosphorylation. (A) Macrophages were pretreated with vehicle or curcumin (25µM) for 1 h, and then treated with
50µg/ml oxLDL for 10, 20, and 60min, and assayed by Western blot using indicated antibodies. (B–D) Protein quantification was carried out by densitometric
analysis. Normalized proteins of JNK, p-JNK, ERK, p-ERK, p38, and p-p38 were normalized based on the internal control β-actin. (E,F) Macrophages were pretreated
with vehicle, curcumin or specific p38 inhibitor (SB203580, 10µM). The addition of a specific p38 inhibitor efficiently blocks oxLDL-stimulated MMP-9 and EMMPRIN
expression. *P < 0.05 when compared with the control group, and (NS) P > 0.05 when compared with the control group.
et al., 2014), Huang et al. also showed curcuminoids suppress
matrix invasion during monocyte-macrophage differentiation
(Huang et al., 2015). There is strong evidence that oxLDL
plays a critical role in atherogenesis and profoundly influences
the stability of atherosclerotic plaques (Zeibig et al., 2011;
Pawlak et al., 2012). Monocytes/macrophages play an essential
role during the various stages of atherosclerosis, including
stabilization of atherosclerotic plaque, especially EMMPRIN and
MMP-9 overexpression by macrophages in patient with high
oxLDL (Schmidt et al., 2008; Gostiljac et al., 2011).
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In the present study, our results showed that curcumin
significantly reduced MMP-9 and EMMPRIN expression under
the stimulation of oxLDL in macrophages, which means that
curcumin could be a potential therapeutic agent for inhibiting
plaque rupture or retarding atherosclerosis. oxLDL increased
EMMPRIN and MMP-9 expression through NF-κB and p38
MAPK pathways and the role of elevated NF-κB and p38 MAPK
activity in oxLDL induced atherosclerotic plaque rupture was
previous demonstrated (Kojima et al., 2010; Yi et al., 2012), which
is in agreement with other studies (Kim et al., 2001; Xie et al.,
2011; Radhika and Sudhakaran, 2013). Results presented here
indicated that NF-κB and p38 MAPK is constitutively active in
oxLDL stimulated macrophages. NF-κB has been reported to be
the most important factor regarding oxLDL induced EMMPRIN
and MMP-9 activation (Singh et al., 2008; Baker et al., 2011;
Park and Hong, 2016). Studies have reported that the mutation
of MMPs promoters area which binds to NF-κB resulted in
downregulation of MMPs in macrophages, and overexpression
of IκB-α protein had the same effect (Monaco et al., 2004;
Ogawa et al., 2004; Rhee et al., 2007). Therefore, NF-κB is a
promising therapeutic target for ameliorating plaque formation
and rupture. Our study showed that curcumin blocked NF-κB
p65 nuclear translocation and inhibited the phosphorylation of
IκB-α stimulated by oxLDL in macrophages, indicating that NF-
κB activation was inhibited by curcumin. Our study further
demonstrated that oxLDL induced EMMPRIN and MMP-9
expression can be reduced by NF-κB inhibitor. Consistent with
our data, curcumin was shown to inhibit the activation of NF-κB
(Kao et al., 2016; Ruiz de Porras et al., 2016), Bharat et al. has
reported curcumin down-regulates the constitutive activation of
NF-κB and IκBα kinase in humanmultiple myeloma cells (Bharti
et al., 2003).
In this study, we found that oxLDL induced the
phosphorylation of p38, JNK, and ERK1/2. Through inhibiting
p38 and JNK phosphorylation, curcumin decreased the
expression of MMP-9 and EMMPRIN in macrophages. Previous
data indicated that EMMPRIN and MMPs can be regulated by
p38 and JNK pathways and oxLDL triggered foam-cell formation
through activation of p38 and JNK pathways (Kojima et al., 2010;
Gao et al., 2013; Namgaladze et al., 2013; Liang et al., 2016). It has
been reported that curcumin modulated oxLDL-induced CD36
expression via the inhibition of p38 MAPK phosphorylation in
RAW 264.7 murine macrophages (Min et al., 2013). Moreover,
the effects of curcumin on MAPK signaling may through
inhibition of HER2 neu (Hong et al., 1999). Taken together, these
findings indicated that curcumin may decrease EMMPRIN and
MMP-9 expression by inhibiting NF-κB and p38 MAPK activity.
To summarize, our study demonstrated that curcumin
alleviated ox-LDL induced MMP-9 and EMMPRIN expression
in oxLDL stimulated macrophages, which was significantly
mediated by modulating NF-κB and MAPK signaling pathways.
EMMPRIN and MMP-9 represent novel targets to mitigate
plaque development and diminish the burden coronary heart
disease. Thus, our work opens up a new insight into the
regulatory mechanism of EMMPRIN and MMP-9 in combating
plaque rupture by curcumin.
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